Blog
RSS FeedPosted by Michael Wonder on 12 Sep 2022
Nomination for an early re-entry resubmission - what exactly does it mean?
12 September 2022 - We compare and contrast the submissions nominated by the PBAC in March for an early re-entry ...
Posted by Michael Wonder on 21 Jan 2022
National Medicines Policy Review – publication of submissions
21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...
Posted by Michael Wonder on 06 Jul 2021
DoH publishes revised agenda for July 2021 PBAC meeting
6 July 2021 - Agenda revised on the eve of next scheduled meeting. ...
Posted by Michael Wonder on 25 Jul 2019
Application process changes for access to Section 100 - Highly Specialised Drugs medicines
25 July 2019 - From 1 August 2019, hospital authorities will no longer be required to seek separate approval from ...
Posted by Michael Wonder on 07 Jan 2019
PBAC - 2018 in review
7 January 2019 - The PBAC considered 195 submissions in 2018; 173 were considered by the PBAC in 2017. ...
Posted by Michael Wonder on 05 Jun 2017
Deadline approaching
5 June 2017 - Final date close for submissions to controversial drug post-marketing review. ...
Posted by Michael Wonder on 20 Apr 2017
Full Federal Court confirms an application to list medicine on the PBS prior to patent expiry is a non-infringing act
19 April 2017 - Late last week, the Full Federal Court of Australia confirmed that the mere act of filing a ...
Posted by Michael Wonder on 25 Feb 2017
The importance of Swiss-style claims in Australia
24 February 2017 - The Federal Court has recently issued a decision that highlights the importance of including Swiss-style claims ...
Posted by Michael Wonder on 18 Feb 2017
When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?
16 February 2017 - In the most recent judgement in the Australian Lyrica litigation, Nicholas J has delivered an interesting decision ...
Posted by Michael Wonder on 03 Jan 2017
2016 in review
4 January 2017 - The PBAC considered 192 submissions in 2016; 193 were considered by the Committee in 2015. ...
Posted by Michael Wonder on 21 Dec 2016
Summary of the agenda for the PBAC March 2017 meeting
22 December 2016 - The PBAC will consider 40 submissions (23 major & 17 minor) at its next scheduled meeting ...
Posted by Michael Wonder on 09 Oct 2016
Guild submission to Pharmacy Review
5 October 2016 - The Pharmacy Guild of Australia has lodged its submission in response to the Review of Pharmacy ...
Posted by Michael Wonder on 25 Aug 2016
Submissions to the review of pharmacy remuneration and regulation
25 August 2016 - Public submissions to the review have been made public. ...
Posted by Michael Wonder on 24 Aug 2016
Summary of the agenda for the PBAC November 2016 meeting
24 August 2016 - The PBAC will consider 66 submissions (34 major & 32 minor) at its next scheduled meeting in ...
Posted by Michael Wonder on 19 Aug 2016
Post-market review of biological disease modifying anti-rheumatic drugs to treat severe chronic plaque psoriasis and of pulmonary arterial hypertension medicines
19 August 2016 - The public consultation process on the draft terms of reference for the two post-market reviews has closed. ...